2: Convalescent Plasma Therapy








References*
- Dean, L. Blood and the cells it contains. National Center for Biotechnology Information (1970).
- The immune system – Canadian Cancer Society. www.cancer.ca (2014).
- The plasma cells – Canadian Cancer Society. www.cancer.ca (2014).
- Marano, G. et al. Convalescent plasma: new evidence for an old therapeutic tool? (2016).
- Chaplin, D. D. Overview of the immune response. J Allergy Clin Immunol (2010).
- Keller, M. A. & Stiehm, E. R. Passive immunity in prevention and treatment of infectious diseases. Clinical microbiology reviews (2000).
- Component 3: Clinical Trials. CCPP19 (2020).
- Weiqian, D., Haihui, G., Sha, H., Potential benefits, mechanisms, and uncertainties of…: Blood Science. LWW (2020).
- Plasma and Serum Preparation. Thermo Fisher Scientific – US (2007).
- Duan, K. et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. PNAS (2020).
- Root, H., Bartelt, L. & Gilligan, P. The Promise of COVID-19 Convalescent Plasma Therapy. ASM.org (2020).
- Mair-Jenkins, J. et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. The Journal of infectious diseases (2015).
- Anurag N. Malani, M. D. Patient Information: Convalescent Plasma and COVID-19. JAMA (2020).
- Chai, K. L., Valk, S. J., Piechotta, V., Kimber, C., Monsef, I., Doree, C., Wood, E. M., Lamikanra A. A., Roberts D. J., McQuilten Z., So-Osman C., Estcourt L. J., Skoetz N. Is plasma from people who have recovered from COVID-19 an effective treatment for people with COVID-19? Cochrane Database of Systematic Reviews (2020).
- Government of Canada, H. C. Clinical trial looking at the potential use of convalescent plasma to treat COVID-19. Recalls and safety alerts (2020).